Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants

Liis Leitsalu, Marili Palover, Timo Tõnis Sikka, Anu Reigo, Mart Kals, Kalle Pärn, Tiit Nikopensius, Tõnu Esko, Andres Metspalu, Peeter Padrik, Neeme Tõnisson
doi: https://doi.org/10.1101/2020.06.29.20139691

Data Availability

All results generated in the study are provided in the manuscript and as Supplementary Tables.

Back to top
Posted June 30, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants
Liis Leitsalu, Marili Palover, Timo Tõnis Sikka, Anu Reigo, Mart Kals, Kalle Pärn, Tiit Nikopensius, Tõnu Esko, Andres Metspalu, Peeter Padrik, Neeme Tõnisson
medRxiv 2020.06.29.20139691; doi: https://doi.org/10.1101/2020.06.29.20139691
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area